Padmanabh P. Bhatt

Insider Reports History

Location
C/O Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Padmanabh P. Bhatt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Sr. VP of IP, CSO Common Stock 13.7K $664K $48.38 Nov 13, 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Sr. VP of IP, CSO Restricted Stock Unit 2.5K $97.9K $39.15 Feb 23, 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Sr. VP of IP, CSO Performance Share Unit 1.5K $0 $35.31 Nov 13, 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Sr. VP of IP, CSO Performance Share Units 0 $0 $39.15 Feb 21, 2025 Direct
SUPERNUS PHARMACEUTICALS, INC. Sr. VP of IP, CSO Employee Stock Option (Right to Buy) 20K Feb 19, 2025 Direct

Insider Reports Filed by Padmanabh P. Bhatt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SUPN SUPERNUS PHARMACEUTICALS, INC. Nov 13, 2025 1 $0 4 Nov 17, 2025 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Aug 25, 2025 3 -$24.1K 4 Aug 27, 2025 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Aug 7, 2025 1 $0 4 Aug 8, 2025 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Mar 5, 2025 3 -$49.1K 4 Mar 5, 2025 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 21, 2025 9 -$33.7K 4 Feb 24, 2025 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 19, 2025 2 $0 4 Feb 21, 2025 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 4, 2025 3 -$95.6K 4 Feb 5, 2025 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Jan 28, 2025 1 $0 4/A Feb 5, 2025 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Jan 27, 2025 7 -$32.8K 4 Jan 29, 2025 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Dec 3, 2024 6 -$256K 4 Dec 4, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Aug 20, 2024 3 -$16.9K 4 Aug 20, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Aug 1, 2024 1 $0 4 Aug 14, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Mar 21, 2024 3 -$145K 4 Mar 25, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Mar 20, 2024 3 -$4K 4 Mar 22, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Mar 19, 2024 3 -$124K 4 Mar 21, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Mar 13, 2024 6 -$1.01M 4 Mar 15, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Mar 12, 2024 3 -$77.7K 4 Mar 14, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 26, 2024 3 -$105K 4 Feb 28, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2024 3 -$18.5K 4 Feb 27, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2024 5 -$10.4K 4 Feb 26, 2024 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Sep 7, 2023 3 -$37.9K 4 Sep 7, 2023 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Aug 23, 2023 1 $0 4 Aug 25, 2023 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. May 11, 2023 2 $0 4 May 12, 2023 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. May 4, 2023 1 $0 4 May 8, 2023 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Apr 11, 2023 1 $0 4 Apr 12, 2023 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2023 2 $0 4 Feb 27, 2023 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2023 2 $0 4 Feb 24, 2023 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Jan 17, 2023 3 -$149K 4 Jan 19, 2023 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Jan 6, 2023 3 -$5.35K 4 Jan 9, 2023 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Dec 1, 2022 3 -$142K 4 Dec 2, 2022 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Nov 11, 2022 3 -$175K 4 Nov 15, 2022 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Nov 9, 2022 3 -$18K 4 Nov 14, 2022 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Jul 15, 2022 1 $0 4 Aug 5, 2022 Sr. VP of IP, CSO
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2022 2 $0 4/A Feb 25, 2022 Sr. VP of IP, CSO